The global fragment analysis market size is projected to reach USD 584.2 million by 2033, growing at a CAGR of 9.75% from 2025 to 2033, according to a new report by Grand View Research, Inc. The market is witnessing robust growth, driven by the increasing demand for high-throughput, accurate, and reproducible analysis of nucleic acids and proteins across research, clinical, and forensic applications. Researchers and labs need fragment analysis solutions that guarantee accurate sizing, quantification, and detection of DNA, RNA, and protein fragments as genomics, proteomics, and molecular diagnostics continue to grow.
Advanced capillary electrophoresis (CE) platforms, microfluidic systems, and automated high-throughput instruments are gradually replacing traditional manual electrophoresis techniques because they offer faster, more dependable, and scalable analysis. Multiplexing capabilities, increased sensitivity, and integration with downstream processes such as PCR, gene expression profiling, and next-generation sequencing (NGS) are significant advancements.
Accurate genotyping, mutation detection, microsatellite instability analysis, and quality control for molecular diagnostics, forensics, and biopharmaceutical development are made possible by high-performance reagents, kits, and software tools, which are now crucial parts of fragment analysis workflows. The market is growing due to strict regulations, the increasing use of precision medicine, and the expanding application of fragment analysis in clinical research, drug development, and personalized healthcare.
Request a free sample copy or view report summary: Fragment Analysis Market Report
By product & service, the reagents & consumables segment accounted for the largest market share of 48.94% in 2024. The high-volume use of PCR primers, fluorescent dyes, DNA ladders, size standards, electrophoresis consumables, and NGS-compatible fragment libraries across genomics and molecular diagnostics workflows drives this leadership.
By technology, capillary electrophoresis held the leading share of 42.54% in 2024. The widespread adoption of automated CE instruments and enhanced multi-capillary platforms for high-throughput sequencing has further strengthened its market share.
By application, the genotyping & polymorphism analysis segment dominated the market with a revenue share of 36.26% in 2024. Growing use of STR and SNP profiling for genetic diversity analysis, linkage studies, forensic DNA testing, plant and animal breeding, and ancestry mapping has fueled demand.
By end use, academic & research institutes captured the largest revenue share of 38.34% in 2024. Their dominance is supported by increasing investments in genomics research, population genetics, cancer biomarker studies, infectious disease surveillance, and agricultural biotechnology programs.
Grand View Research has segmented the global fragment analysis market based on product & service, technology, application, end use, and region:
Fragment Analysis Product & Service Scope Outlook (Revenue, USD Million, 2021 - 2033)
Instruments
Reagents & Consumables
PCR master mixes
Fluorescent dyes and labels
DNA size standards & ladders
Capillary arrays
Others
Services
Fragment Analysis Technology Scope Outlook (Revenue, USD Million, 2021 - 2033)
Capillary Electrophoresis
Polymerase Chain Reaction
DNA Sequencing
Others
Fragment Analysis Application Outlook (Revenue, USD Million, 2021 - 2033)
Genotyping & Polymorphism Analysis
SNP and Indel Genotyping
Microsatellite / STR / VNTR Analysis
Others
Molecular Diagnostics
Forensic & Paternity Testing
Agricultural & Animal Genomics
Others
Fragment Analysis End Use Outlook (Revenue, USD Million, 2021 - 2033)
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Biotechnology & Pharmaceutical Companies
Others
Fragment Analysis Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
India
Japan
Australia
Thailand
South Korea
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Fragment Analysis Market
Thermo Fisher Scientific, Inc.
Danaher
Agilent Technologies
NimaGen
Genetika Science
Promega Corporation
LGC
Eurofins Genomics
MCLAB
SoftGenetics
"The quality of research they have done for us has been excellent..."